Therefore, further studies are needed in order to better clarify, and maybe selectively potentiate, the cytotoxic and antitumoral effects of ROS intervention as well as the protective role of antioxidant compounds in preventing and contrasting the development of NF1-related cancers. The gene discussed is NF1; the disease is cancer.